Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2014-03-21

European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease

View source ↗

Summary

The European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications